ÂÜÀòÂÒÂ×

Matthew Remillard is an accomplished professional in the field of molecular biology and consulting, currently serving as a Managing Consultant and previously as a Senior Consultant at Bluestar BioAdvisors, LLC since July 2022. Prior experience includes roles as a Senior Associate at Evercore from May 2019 to July 2022 and as an Associate at Goldman Sachs between July 2016 and May 2019. Matthew’s academic background includes a PhD in Molecular Biology from Princeton University, where research focused on meiosis regulation in yeast under Professor Mark Rose, as well as prior work in the Coller lab investigating quiescence using human fibroblasts. Matthew also holds a Bachelor of Science in Biological Sciences from Carnegie Mellon University. Additional experience includes serving as a Community Associate at Princeton University, organizing programs for graduate students, and working as a Research Assistant at the National Surgical Adjuvant Breast and Bowel Project.